The FDA recently approved a novel medication called Mounjaro. See how this once-weekly therapy works to significantly lower A1c and promote weight loss in people with type 2 diabetes.
read more →
Medicare recently launched a new program called the Medicare Part D Senior Savings Model Program to test the impact of giving Medicare beneficiaries 65 and older an increased choice of Part D plans with no deductible and a max copay of $35 per month for insulin and fixed-ratio combination GLP-1 RAs Soliqua and Xultophy.
read more →
The FDA recently approved Wegovy, the first and only once-weekly injection for chronic weight management in adults.
read more →
Dr. Edelman clarifies how SGLTs and GLP-1s affect insulin use, and whether or not they cause hypoglycemia.
read more →
Our international panel of diabetes experts discussed highlights from the ADA’s Scientific Sessions, and lead a Q&A on some of the most important advances in diabetes.
read more →
